Interclean Shanghai

Eaton Scientific Engages Cislo & Thomas LLP to Advance Tropine 3 Hot Flash Treatment Patent Applicat

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

EU Begins Revision of Medical Device...

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical...

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI...

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...
Eaton Scientific Systems, Ltd. ("Eaton" or the "Company") a wholly-owned subsidiary of Pristine Solutions, Inc. is pleased to announce that it has engaged full service intellectual property law firm Cislo & Thomas LLP to advance its Tropine 3 patent application and intellectual property strategy.  Tropine 3, is a patent pending novel indication of FDA approved homatropine for non-hormonal treatment of hot flashes in pre-menopausal, peri-menopausal, and post-menopausal women.
 
"As a rapidly emerging drug development company, we anticipate that we will be required to rely heavily on our intellectual property rights, in particular our potential patents.  Working with a well-respected and established intellectual property law firm will be critical to our on-going success," stated Michael Borkowski, CEO of Eaton Scientific.  "In the modern drug development business model, a well-crafted and guarded patent is often a company's most crucial asset in a sector that is extremely research-intensive, high risk, and with relatively low imitation costs.  We will continue to work closely with the professionals at Cislo & Thomas to ensure Eaton Scientific has a solid IP strategy and maximizes its patent values."
Founded in 1979, Cislo & Thomas LLP is a full service, California-based intellectual property law firm providing patent, trademark, copyright, and trade secret legal services to the business and entertainment communities, both locally and worldwide through a network of associates in every major country of the world.  With offices in Santa Monica, Westlake Village, and Santa Barbara, Cislo & Thomas attorneys and paralegals file patents, trademarks, and copyrights, and also use real-world experience in business to effectively litigate these matters in Federal Court. 
 
Each Cislo & Thomas patent attorney is highly trained in various technical disciplines and specialties and are often engineers and scientists in addition to being attorneys admitted to the United States Patent and Trademark Office and the Federal Courts. They are also seasoned attorneys who can handle all forms of intellectual property disputes.  This depth has allowed Cislo & Thomas to become one of the top-rated law firms in the nation, as independently rated by Lexis-Nexis Martindale Hubble and The Bar Register of Preeminent Lawyers, which lists Cislo & Thomas in the top 5% of all law firms in the country.
 
The Company anticipates taking notable steps with regard to its patent portfolio and intellectual property strategy over the coming weeks.
 
About Pristine Solutions, Inc.
Pristine Solutions, Inc., through its wholly-owned subsidiary company, Eaton Scientific Systems, Ltd., holds the intellectual property and global marketing rights to Tropine 3, a patent pending novel indication of an existing FDA approved drug for the non-hormonal treatment of hot flashes in pre-menopausal, peri- menopausal, and post-menopausal women.

Latest stories

Related stories

EU Begins Revision of Medical Device Regulatory Framework

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical Devices Regulation

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI Rollout in the NHS

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »